Page 2,448«..1020..2,4472,4482,4492,450..2,4602,470..»

MS stem cell treatment hailed 'miraculous' as patients make dramatic recovery

Posted: Published on March 9th, 2015

Pioneering treatment has allowed wheelchair-bound patients to run again Patient given high dose of chemotherapy to wipe out faulty immune system Therapy then uses person's own stem cells to fight the devastating disease It may be the first ever treatment tosuccessfullyreverse symptoms of MS By Fiona Macrae for the Daily Mail Published: 13:27 EST, 1 March 2015 | Updated: 02:54 EST, 2 March 2015 11k shares 94 View comments Britons left wheelchair-bound by multiple sclerosis can walk, run and even dance again after being given a pioneering stem cell treatment. Doctors have described the recoveries as miraculous, while patients say they have been given their lives back. The treatment uses a patients own stem cells the bodys master cells to fight the disease. Recovery: MS sufferer Holly Drewerybecame wheelchair-bound after the birth of daughter Isla, but thanks tothe stem cell transplant shecan dance, run and chase after Isla in the park Read more: MS stem cell treatment hailed 'miraculous' as patients make dramatic recovery … Continue reading

Comments Off on MS stem cell treatment hailed 'miraculous' as patients make dramatic recovery

'Stem cell' test could identify most aggressive breast cancers

Posted: Published on March 9th, 2015

Testing breast cancer cells for how closely they resemble stem cells could identify women with the most aggressive disease, a new study suggests. Researchers found that breast cancers with a similar pattern of gene activity to that of adult stem cells had a high chance of spreading to other parts of the body. Assessing a breast cancer's pattern of activity in these stem cell genes has the potential to identify women who might need intensive treatment to prevent their disease recurring or spreading, the researchers said. Adult stem cells are healthy cells within the body which have not specialised into any particular type, and so retain the ability to keep on dividing and replacing worn out cells in parts of the body such as the gut, skin or breast. A research team from The Institute of Cancer Research, London, King's College London and Cardiff University's European Cancer Stem Cell Research Institute identified a set of 323 genes whose activity was turned up to high levels in normal breast stem cells in mice. The study is published today (Wednesday) in the journal Breast Cancer Research, and was funded by a range of organisations including the Medical Research Council, The Institute of … Continue reading

Comments Off on 'Stem cell' test could identify most aggressive breast cancers

Cutting-edge technology optimizes cancer therapy with nanomedicine drug combinations

Posted: Published on March 9th, 2015

UCLA bioengineers develop platform that offers personalized approach to treatment In greater than 90 percent of cases in which treatment for metastatic cancer fails, the reason is that the cancer is resistant to the drugs being used. To treat drug-resistant tumors, doctors typically use multiple drugs simultaneously, a practice called combination therapy. And one of their greatest challenges is determining which ratio and combination -- from the large number of medications available -- is best for each individual patient. Dr. Dean Ho, a professor of oral biology and medicine at the UCLA School of Dentistry, and Dr. Chih-Ming Ho, a professor of mechanical engineering at the UCLA Henry Samueli School of Engineering and Applied Science, have developed a revolutionary approach that brings together traditional drugs and nanotechnology-enhanced medications to create safer and more effective treatments. Their results are published in the peer-reviewed journal ACS Nano. Chih-Ming Ho, the paper's co-corresponding author, and his team have developed a powerful new tool to address drug resistance and dosing challenges in cancer patients. The tool, Feedback System Control.II, or FSC.II, considers drug efficacy tests and analyzes the physical traits of cells and other biological systems to create personalized "maps" that show the most … Continue reading

Comments Off on Cutting-edge technology optimizes cancer therapy with nanomedicine drug combinations

Duluth man to undergo rare, high-tech surgery to receive bionic eye

Posted: Published on March 9th, 2015

February 20, 2015 Updated Feb 20, 2015 at 7:56 PM CDT DULUTH, Minn. (NNCNOW.com) -- Senior Pastor, James Kelm, at True Hope Church in Duluth, is also a self-taught musician. Retinitis Pigmentosa is a genetic disease that damages the retina and robs people of their vision. Rev. Kelm lives in a world he describes as "medium gray." "If I were to walk out into a bright sunny day, I could tell that medium gray becomes a light gray. If I walk out at nighttime or a dark room that medium gray becomes a dark gray," he said. There is no cure for R.P., but a new retinal implant developed by Second Sight is offering hope. James is among the first Minnesotans selected to receive the bionic eye. "It was the first time in my life that actually it was a benefit. The worse my eyes sight was, ha, ha, actually played in my favor." "I love him blind, but I also know I will love him with sight or no sight or however God wants him to be. I will love him through it," said Kimberly, James' wife of seven years. Kimberly says she is excited for her husband, but … Continue reading

Posted in Retinitis Pigmentosa | Comments Off on Duluth man to undergo rare, high-tech surgery to receive bionic eye

Second Sight Medical Products (EYES) Stock Higher Today After Success of Implants

Posted: Published on March 9th, 2015

NEW YORK (TheStreet) -- Shares ofSecond Sight Medical Products (EYES) are higherin morning trading today, up 20.28% to $10.20 after the California-basedmanufacturer of implantable visual prosthetics announced thatall three of the French centers approved to implant itsArgus II Retinal Prosthesis System have successfully completed their first implants in patients with retinitis pigmentosa (RP). In 2014, the Argus II became the first-ever medical device to be named as the recipient of Forfait Innovation, aFrench Government national healthcare reimbursement program, which allowed select hospitals in France to offer this "early access" and innovative treatment to patients with advanced RP. Forfait Innovation provides dedicated support to patients implanted with Argus II, funding the costs of implantation and patients' hospital fees. Now 36 RP patients in France stand to benefit from this technology with this first step in national reimbursement, the company said. Exclusive Report: Jim Cramer's Best Stocks for 2015 "We are pleased to see RP patients, who previously had no treatment option, gain access to this revolutionary device through Forfait Innovation," Second SightCEODr. Robert Greenberg said. "There is great potential for patients in France, as the French government has taken a progressive step in supporting a sometimes overlooked patient population." To date, … Continue reading

Posted in Retinitis Pigmentosa | Comments Off on Second Sight Medical Products (EYES) Stock Higher Today After Success of Implants

Bionic eye helps man see

Posted: Published on March 9th, 2015

Published February 24, 2015 A Minnesota man saw his wife for the first time in 10 years and most of his grandchildren for the first time ever after receiving a bionic eye at the Mayo Clinic earlier this month, ValleyNewsLive.com reported. Allen Zderad, 68, has retinitis pigmentosa, a degenerative, genetic eye disease that affects the part of the retina that translates light into sight. The condition progressively stole the Forest Lake mans vision over the course of his life. Zderad uses a cane to walk and has leaned on his wife, Carmen Zderad, as his sighted guide since losing his ability to see. Ten years, Zderad told Valley News Live of the last time he saw his wife, but I still kiss her with my eyes closed. Zderad is the 15th person to receive the Second Sight Argus II retinal prosthesis system, which the Food and Drug Administration (FDA) approved for implantation in January 2014. The technology reportedly took 25 years and an estimated $300 to $500 million to develop. Implanting the bionic eye involves the insertion of 60 electrodes into the retina. Zderads surgery took about three hours and, two weeks later, he can now see with the artificial … Continue reading

Posted in Retinitis Pigmentosa | Comments Off on Bionic eye helps man see

Husband sees his wife for the first time in a decade after having bionic eye fitted

Posted: Published on March 9th, 2015

Allen Zderad suffered from genetic eye disease called retinitis pigmentosa It gradually wore away the 68-year-old's retina over the course of his life After ten years of being blind, he saw again with the aid of bionic glasses They send electrical signals to electrodes implanted in Mr Zderad's eyes By Jay Akbar For Mailonline Published: 09:11 EST, 20 February 2015 | Updated: 12:15 EST, 20 February 2015 A blind man finally caught a glimpse of the loving wife who acted as his guide for over a decade after being fitted a bionic eye. Allen Zderad screamed with happiness when Carmen came into focus, before embracing his wife and erupting into tears of joy. The man from Forest Lake, Minnesota suffered from a genetic disease called retinitis pigmentosa which stole his eyesight over the course of his life according to Kare. Now thanks to a pair of electronic glasses which send signals to the electrodes planted in his damaged retina's, the 68-year-old has finally been able to see his wife and ten grandchildren again. Regarding the device which took over 200million and decades to develop, he said: 'It's crude but significant, it works.' Scroll down for video Elation: Allen Zderad (left) … Continue reading

Posted in Retinitis Pigmentosa | Comments Off on Husband sees his wife for the first time in a decade after having bionic eye fitted

The Lancet Hematology: Experts warn of stem cell underuse as transplants reach 1 million worldwide

Posted: Published on March 9th, 2015

Since the first experimental bone marrow transplant over 50 years ago, more than one million hematopoietic stem cell transplantations (HSCT) have been performed in 75 countries, according to new research charting the remarkable growth in the worldwide use of HSCT, published in The Lancet Haematology journal. However, the findings reveal striking variations between countries and regions in the use of this lifesaving procedure and high unmet need due to a chronic shortage of resources and donors that is putting lives at risk. HSCT (also known as blood and marrow transplant) is most often used to treat diseases of the blood and several types of cancer such as multiple myeloma or leukaemia. For many people with these diseases the only possibility of a cure is to have a HSCT. The procedure provides healthy cells from either the patient (autologous transplantation) or from a healthy donor (allogeneic transplantation) to replace those lost to disease or chemotherapy. Using data collected by the Worldwide Network for Blood and Marrow Transplantation (WBMT), Professor Dietger Niederwieser from the University Hospital Leipzig in Germany and international colleagues, systematically analysed the growth of HSCT and changes in its use in 194 WHO member countries since the first transplant … Continue reading

Posted in Stem Cell Transplant | Comments Off on The Lancet Hematology: Experts warn of stem cell underuse as transplants reach 1 million worldwide

Deadly shortage of black stem cell donors

Posted: Published on March 9th, 2015

Black South Africans make up about 47 percent of all cancer patients but only 5 percent of donors in the nations bone marrow registry. The gap between those who may need bone marrow or stem cell transplants, and those able to provide them has deadly consequences for cancer patients. Black South Africans make up about 47 percent of all cancer patients but only 5 percent of donors in the nations bone marrow registry Maphoko Nthane, 50, had experienced mysterious and severe backaches for months. Doctors ran test after test, but could find nothing wrong with Nthane. I had a severe back ache for months, she told Health-e News. Whenever I would have that pain, I couldnt sit down I had to walk or stand up. Doctors eventually diagnosed Nthane with Acute Lymphoblastic Leukaemia, a severe form of cancer affecting a patients blood and bone marrow. After I was diagnosed I thought I was going to die I didnt know that people with leukaemia could live, Nthane said. My husband was just as traumatised and as a result he didnt know how to support me. Nthanes cancer failed to respond to standard chemotherapy and ultimately a stem cell transplant saved her … Continue reading

Posted in Stem Cell Transplant | Comments Off on Deadly shortage of black stem cell donors

Ultherapy in Frederick, MD – Video

Posted: Published on March 9th, 2015

Ultherapy in Frederick, MD Cosmetic Services at Frederick Dermatology Associates Center for Aesthetic Medicine: Dr. Moe and Dr. Hogan, Dermatologists at Frederick Dermatology Associates Center for Aesthetic Medicine... By: Frederick Dermatology Associates … Continue reading

Posted in Aesthetic Medicine | Comments Off on Ultherapy in Frederick, MD – Video

Page 2,448«..1020..2,4472,4482,4492,450..2,4602,470..»